|
Post by marykudro on Jul 5, 2022 5:35:08 GMT -5
The sorafenib IP 200 mg tablets are formulated as an oral anticancer medication, which are available only by a valid prescription. Sorafenib has not been assessed in children. The sorafenib tablets ip 200 mg has been assessed in the patients with liver cancer that is hard to be treated with surgery, in patients with advanced kidney cancer, and in patients with DTC, a type of thyroid cancer, that can not be treated with radioactive iodine. Only you and your doctor can determine if treatment is appropriate for you. Recommended daily dose is 2 tablets, 2 times a day, taken by mouth 12 hours apart, without food 1 hour before or 2 hours after a meal. Sorafenib therapy will not cure your cancer, but it can slow or temporarily stop the growth or spread of cancerous cells. This is known as stable disease. To place an enquiry, kindly contact us through TOLL-FREE: 1800-889-1064 or Email: info@ikrispharmanetwork.com.
|
|